Resolution of disseminated molluscum contagiosum with highly active anti-retroviral therapy (HAART) in patients with AIDS

European Journal of Dermatology

Volumn 9, Issue 3, 1999, Pages 211-213

  Calista, Donato ^a   Boschini, Antonio ^b   Landi, Giorgio ^a  

^a BUFALINI HOSPITAL   (Italy)

^b San Patrignano Medical Centre   (Italy)

Author keywords

AIDS; HAART; HIV; Immunosuppression; Molluscum contagiosum; Poxvirus

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPHOCYTE COUNT; MALE; MOLLUSCUM CONTAGIOSUM; POXVIRUS; REMISSION; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; HUMANS; INDINAVIR; LAMIVUDINE; MALE; MOLLUSCUM CONTAGIOSUM; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 0032903591     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. 1. Gottlieb SL, Mycowski PL. Molluscum contagiosum. Int J Dermatol 1994; 33: 453-61.
2. 2. Moyle G, Gazzard B. Current knowledge and future prospects for the use of HIV protease inhibitors. Drugs 1996; 51: 701-12.
3. 3. Deeks S, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors. A review for clinicians. JAMA 1997; 277: 145-53.
4. 4. Schwartz JJ, Mycowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection: a review of 27 patients. J Am Acad Dermatol 1992; 17: 583-8.
5. 5. Gulick RM, Mellors JW, Havlir D. et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337: 734-9.
6. 6. Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV) infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996; 173: 321-9.